Cargando…

Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications

Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Mi, Kun, Hou, Yixuan, Hui, Tianyi, Zhang, Lan, Tao, Yanfei, Liu, Zhenli, Huang, Lingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456269/
https://www.ncbi.nlm.nih.gov/pubmed/37623842
http://dx.doi.org/10.3390/metabo13080897
_version_ 1785096655891070976
author Sun, Lei
Mi, Kun
Hou, Yixuan
Hui, Tianyi
Zhang, Lan
Tao, Yanfei
Liu, Zhenli
Huang, Lingli
author_facet Sun, Lei
Mi, Kun
Hou, Yixuan
Hui, Tianyi
Zhang, Lan
Tao, Yanfei
Liu, Zhenli
Huang, Lingli
author_sort Sun, Lei
collection PubMed
description Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs) urgently need to be solved, and combination has attracted a lot of attention from pharmaceutical researchers. At present, DDI is often evaluated and investigated from two perspectives: pharmacodynamics and pharmacokinetics. However, in some special cases, DDI cannot be accurately evaluated from a single perspective. Therefore, this review describes and compares the current DDI evaluation methods based on two aspects: pharmacokinetic interaction and pharmacodynamic interaction. The methods summarized in this paper mainly include probe drug cocktail methods, liver microsome and hepatocyte models, static models, physiologically based pharmacokinetic models, machine learning models, in vivo comparative efficacy studies, and in vitro static and dynamic tests. This review aims to serve as a useful guide for interested researchers to promote more scientific accuracy and clinical practical use of DDI studies.
format Online
Article
Text
id pubmed-10456269
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104562692023-08-26 Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications Sun, Lei Mi, Kun Hou, Yixuan Hui, Tianyi Zhang, Lan Tao, Yanfei Liu, Zhenli Huang, Lingli Metabolites Review Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs) urgently need to be solved, and combination has attracted a lot of attention from pharmaceutical researchers. At present, DDI is often evaluated and investigated from two perspectives: pharmacodynamics and pharmacokinetics. However, in some special cases, DDI cannot be accurately evaluated from a single perspective. Therefore, this review describes and compares the current DDI evaluation methods based on two aspects: pharmacokinetic interaction and pharmacodynamic interaction. The methods summarized in this paper mainly include probe drug cocktail methods, liver microsome and hepatocyte models, static models, physiologically based pharmacokinetic models, machine learning models, in vivo comparative efficacy studies, and in vitro static and dynamic tests. This review aims to serve as a useful guide for interested researchers to promote more scientific accuracy and clinical practical use of DDI studies. MDPI 2023-07-29 /pmc/articles/PMC10456269/ /pubmed/37623842 http://dx.doi.org/10.3390/metabo13080897 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sun, Lei
Mi, Kun
Hou, Yixuan
Hui, Tianyi
Zhang, Lan
Tao, Yanfei
Liu, Zhenli
Huang, Lingli
Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title_full Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title_fullStr Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title_full_unstemmed Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title_short Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
title_sort pharmacokinetic and pharmacodynamic drug–drug interactions: research methods and applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456269/
https://www.ncbi.nlm.nih.gov/pubmed/37623842
http://dx.doi.org/10.3390/metabo13080897
work_keys_str_mv AT sunlei pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT mikun pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT houyixuan pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT huitianyi pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT zhanglan pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT taoyanfei pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT liuzhenli pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications
AT huanglingli pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications